We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a pu... Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Show more
Revenue of $1.099 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $167 Million Adjusted EBITDA (non-GAAP)1 of $180 Million Revenue Grew 18% as Reported and 20% on a Constant...
21 Poster Presentations include Evaluations of Consumer, Pharmaceutical, Surgical and Vision Care Products and Pipeline Programs, Including a Novel Dry Eye Nutritional Supplement Bausch + Lomb...
Novel Supplement Shown to Address Signs and Symptoms of Dry Eyes, All Primary Endpoints Achieved Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue® Eye Care...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on...
Presentations Will Feature Studies Evaluating TENEO™ Excimer Laser Platform, MIEBO® (Perfluorohexyloctane Ophthalmic Solution) and enVista® Envy* and IC-8® Apthera™ IOLs Bausch + Lomb Corporation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.85 | -5.7200538358 | 14.86 | 15.15 | 13.64 | 281919 | 14.80920057 | CS |
4 | -2.37 | -14.4688644689 | 16.38 | 16.75 | 13.64 | 542375 | 14.90730525 | CS |
12 | -0.31 | -2.16480446927 | 14.32 | 17.695 | 13.64 | 463481 | 15.60804833 | CS |
26 | -2.3 | -14.1017780503 | 16.31 | 17.695 | 13.62 | 508649 | 15.52239118 | CS |
52 | -3.49 | -19.9428571429 | 17.5 | 21.95 | 13.62 | 485805 | 16.94435206 | CS |
156 | -4.49 | -24.2702702703 | 18.5 | 21.95 | 12.2 | 615103 | 16.43413307 | CS |
260 | -4.49 | -24.2702702703 | 18.5 | 21.95 | 12.2 | 615103 | 16.43413307 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions